Clinical Trial Update: Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating abemaciclib with pembrolizumab in locally advanced unresectable or metastatic gastroesophageal adenocarcinoma was terminated; results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Gastroesophageal Junction or Stomach
• Gastroesophageal Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Nataliya Uboha | Conditions: Gastroesophageal Cancer, Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2024-02-20